Kane Biotech Inc. (KNBIF) 的整体财务健康评级为 C 综合评分为 0 （满分5分）.
这表明公司面临一些值得关注的财务挑战. 评级截至 2026-03-20.
| 日期 | 评级 | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-03-20 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-19 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-16 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-13 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-09 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-19 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-12 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
